Which indication is primary for using a HMG-CoA reductase inhibitor for a patient diagnosed with angina pectoris and an elevated LDL cholesterol level?
Understand the Problem
The question is asking for the primary indication of using an HMG-CoA reductase inhibitor in the context of a patient with angina pectoris and high LDL cholesterol levels. It requires understanding the use of these inhibitors in medical treatment.
Answer
Lower cholesterol levels.
The primary indication for using a HMG-CoA reductase inhibitor for a patient with angina pectoris and elevated LDL cholesterol is to lower cholesterol levels.
Answer for screen readers
The primary indication for using a HMG-CoA reductase inhibitor for a patient with angina pectoris and elevated LDL cholesterol is to lower cholesterol levels.
More Information
Statins are primarily used to lower LDL cholesterol and decrease the risk of cardiac events in patients with cardiovascular disease.
Tips
Confusing the primary indication of statins with other cardiac treatments like vasodilators.
Sources
- Efficacy of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase... - pmc.ncbi.nlm.nih.gov
- Lipitor - accessdata.fda.gov - accessdata.fda.gov
AI-generated content may contain errors. Please verify critical information
